This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of stable COPD

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • management strategy of stable COPD should be predominantly based on the assessment of symptoms and future risk of exacerbations
  • all individuals who smoke should be strongly encouraged and supported to quit
  • main treatment goals are reduction of symptoms and future risk of exacerbations
  • management strategies include pharmacological and non-pharmacological interventions.


© 2020, Global Initiative for Chronic Obstructive Lung Disease, available from, published in Fontana, WI, USA.


  • a major differential diagnosis is asthma. In some patients with chronic asthma, a clear distinction from COPD is not possible using current imaging and physiological testing techniques. In these patients, current management is similar to that of asthma
  • Alpha-1 antitrypsin deficiency (AATD) screening:
    • the World Health Organization recommends that all patients with a diagnosis of COPD should be screened once especially in areas with high AATD prevalence
      • a low concentration (< 20% normal) is highly suggestive of homozygous deficiency
        • family members should also be screened


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.